Company Ticker News January 18, 2022FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older 0 0 Share
Company Ticker News January 17, 20224 Large-Cap Drugmaker Stocks to Watch Despite Omicron Woes 0 0 Share